Investors / Spain / Capital Cell
Capital Cell
Investor · Barcelona, Spain · Europe
Capital Cell is an online investment platform authorized by the Spanish CNMV (PFP no. 12) and licensed as a European Crowdfunding Service Provider, focused on biotechnology and life sciences companies. It lets individual investors co-invest alongside specialized funds in selected biotech and life science rounds, and offers a secondary market for trading positions.
Invests inHealthcare & Biotech
In its own wordsbiotechlife scienceshealthcarediagnosticstherapeuticscrowdfunding
Your fit with Capital Cell
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsCapital Cell lists 25 checked portfolio companies on its own site and is named in 6 funding rounds, 1 of them as lead. Its most frequent entry is Seed, 60% of the companies with a known first round. Its largest themes are Healthcare & Biotech (93%), Food & Agriculture (4%) and Industrial & Manufacturing (4%). 53% of its companies are based in France. It invests most often alongside Agoranov, Axon Partners Group and Creative Destruction Lab.
Counts come from funding rounds that name Capital Cell, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Capital Cell's whole history. Rounds on record name 6 companies; its own site lists 25. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundCapital Cell does not state its stages on its site, so only what it does is shown.
Show as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 60% |
| Series A | 40% |
| Series B | 0% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 1 | 1 |
| '23 | 0 | 0 |
| '24 | 1 | 0 |
| '25 | 3 | 0 |
| '26 | 1 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 60th | 25 companies |
| Recent activity | 69th | 2 rounds in 12 months |
| Early stage | 76th | 60% of entries at pre-seed or seed |
| Evidence | 72th | 8% of companies confirmed by a round |
| Sector focus | 96th | 93% in its largest sector |
| Reach | 78th | 5 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Agoranov | 2 |
| Axon Partners Group | 1 |
| Creative Destruction Lab | 1 |
| Easo Ventures | 1 |
| EnjoyVenture | 1 |
| FoodLabs | 1 |
| Grid Exponential | 1 |
| IRDI Capital Investissement | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers25100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 93% | 15% |
| Food & Agriculture | 4% | 3% |
| Industrial & Manufacturing | 4% | 7% |
Co-investor network
who it backs companies with, and who they back togetherCompare Capital Cell head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Capital Cell| Date | Company | Stage |
|---|---|---|
| 3 Mar 2026 | Seed | |
| 2 Dec 2025 | Series A | |
| 26 Aug 2025 | Seed | |
| 19 Feb 2025 | Seed | |
| 19 Oct 2022 | Series A Led |
Round details for Capital Cell
Amounts, full round histories and every co-investor in Capital Cell's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
25 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| AbTx is a preclinical stage biotech company developing the next generation of oncology treatments to treat incurable cancers | Healthcare & Biotech | Portfolio page | ||
| ALA Diagnostics develops and commercializes in vitro diagnostic kits for diseases with high prevalence and unmet medical needs. | Healthcare & Biotech | Portfolio page | ||
| Alaya.bio is a preclinical-stage biotech company developing in vivo CAR-T cell therapies. | Healthcare & Biotech | Portfolio page | ||
| Aspivix develops and commercializes medical devices, specifically a suction-based cervical stabilizer for gynecological procedures | Healthcare & Biotech | Portfolio page | ||
| Axoltis Pharma develops innovative drugs to treat patients with degenerative or traumatic neurological disorders | Healthcare & Biotech | Dec 2025Series A | Page + round | |
| Cardiawave has developed a unique non-invasive ultrasound therapy for the treatment of calcific aortic stenosis. | Healthcare & Biotech | Portfolio page | ||
| DynamicsVR creates software using Virtual Reality for physiotherapy rehabilitation | Healthcare & Biotech | Mar 2026Seed | Page + round | |
| E-mirgency is a cutting-edge technological startup that transforms cancer detection through miRNA technology | Healthcare & Biotech | Portfolio page | ||
| EVis Bioscience develops a next-generation non-viral vector for targeted gene therapy and innovative gene delivery systems for targeted and personalized medicine. | Healthcare & Biotech | Portfolio page | ||
| Freeox Biotech is an innovative late-stage clinical company singularly focused on the discovery and development of Cerebrovascular Protective Therapeutics | Healthcare & Biotech | Portfolio page | ||
| Kervalion develops 3D printed bone grafts for dental implant surgery | Healthcare & Biotech | Portfolio page | ||
| Kynda uses bio reactors to ferment mushroom mycelium to produce alternative proteins for the food industry | Food & AgricultureHealthcare & Biotech | Feb 2025Seed | Funding round | |
| Lucky Loop Medical develops a surgical brush for the diagnosis of pancreatic cysts. | Healthcare & Biotech | Portfolio page | ||
| METHYS Dx develops tests for analyzing circulating tumor DNA in patients with advanced cancers. | Healthcare & Biotech | Portfolio page | ||
| Nanogrow is developing cutting-edge biological treatments combining their unique Single-domain Antibodies-platform with the most convenient formulation. | Healthcare & BiotechHealthcare & Biotech | Portfolio page | ||
| Oragen Therapeutics is a biotechnology company that develops oral genetic medicines designed to act locally in the intestine and reach beyond the liver. | Healthcare & Biotech | Portfolio page | ||
| Robopedics makes robots to help people with disabilities caused by stroke to walk again | Healthcare & Biotech | Oct 2022Series A | Funding round | |
| Social Cooling develops and sells installation-free air conditioning systems. | Industrial & Manufacturing | Aug 2025Seed | Funding round | |
| Soqut Imaging develops a non-invasive diagnostic imaging tool for early detection of patients at risk of liver disease using MRI | Healthcare & Biotech | Portfolio page | ||
| Stereodive creates software for multidisciplinary stereotactic neurological intervention planning | Healthcare & Biotech | Portfolio page |
About this data
site last read 8 Nov 2026- Site
- capitalcell.com
- Last read
- 8 Nov 2026
- Watching since
- 6 Nov 2026
- Rounds since
- 19 Oct 2022
- Companies checked
- 25
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Capital Cell's profile as data
Pull Capital Cell's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/capitalcell.com
# also
GET /v1/firms/capitalcell.com/portfolio
GET /v1/firms/capitalcell.com/coinvestors
GET /v1/firms/capitalcell.com/news